KYORIN Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	14,031	15,021	13,886	19,394	26,994	27,445
Short-Term Investments	3,778	1,493	99	-	500	3,399
Cash & Short-Term Investments	17,809	16,514	13,985	19,394	27,494	30,844
Cash Growth	14.82%	18.08%	-27.89%	-29.46%	-10.86%	-6.30%
Receivables	45,118	47,541	47,672	47,250	41,636	40,409
Inventory	70,135	65,730	53,470	48,025	42,217	38,568
Other Current Assets	6,112	6,349	4,183	4,361	5,029	4,206
Total Current Assets	139,174	136,134	119,310	119,030	116,376	114,027
Property, Plant & Equipment	30,458	30,303	28,950	25,834	24,334	23,896
Long-Term Investments	20,387	21,831	23,882	24,469	27,140	25,074
Other Intangible Assets	4,246	4,757	5,088	5,393	3,289	3,785
Long-Term Deferred Tax Assets	-	591	448	1,316	783	343
Other Long-Term Assets	1	2	1	3	2	1
Total Assets	194,266	193,618	177,679	176,045	171,924	167,126
Accounts Payable	12,632	15,517	14,265	13,762	10,896	6,985
Accrued Expenses	1,092	2,226	2,198	2,182	2,295	2,206
Short-Term Debt	9,100	7,400	10,100	10,300	10,300	10,300
Current Portion of Long-Term Debt	188	200	10,200	-	-	-
Current Portion of Leases	-	135	87	134	147	137
Current Income Taxes Payable	986	3,176	923	2,027	530	476
Other Current Liabilities	9,628	6,457	7,718	6,578	8,014	7,303
Total Current Liabilities	33,626	35,111	45,491	34,983	32,182	27,407
Long-Term Debt	20,096	20,235	435	10,636	10,836	11,036
Long-Term Leases	-	469	124	207	341	409
Pension & Post-Retirement Benefits	286	575	117	3,721	2,885	2,584
Long-Term Deferred Tax Liabilities	256	59	185	-	175	293
Other Long-Term Liabilities	1,133	885	545	1,038	998	736
Total Liabilities	55,397	57,334	46,897	50,585	47,417	42,465
Common Stock	700	700	700	700	700	700
Additional Paid-In Capital	4,752	4,752	4,752	4,752	4,752	4,752
Retained Earnings	132,173	142,789	136,774	134,396	132,710	132,557
Treasury Stock	-5,929	-17,349	-17,350	-17,666	-17,671	-17,671
Comprehensive Income & Other	7,173	5,392	5,906	3,278	4,016	4,323
Shareholders' Equity	138,869	136,284	130,782	125,460	124,507	124,661
Total Liabilities & Equity	194,266	193,618	177,679	176,045	171,924	167,126
Total Debt	29,384	28,439	20,946	21,277	21,624	21,882
Net Cash (Debt)	-11,575	-11,925	-6,961	-1,883	5,870	8,962
Net Cash Growth	-	-	-	-	-34.50%	-3.89%
Net Cash Per Share	-201.48	-207.58	-121.29	-32.86	102.44	156.42
Filing Date Shares Outstanding	57.45	57.46	57.45	57.3	57.3	57.3
Total Common Shares Outstanding	57.45	57.46	57.45	57.3	57.3	57.3
Working Capital	105,548	101,023	73,819	84,047	84,194	86,620
Book Value Per Share	2417.36	2371.97	2276.50	2189.38	2172.82	2175.51
Tangible Book Value	134,623	131,527	125,694	120,067	121,218	120,876
Tangible Book Value Per Share	2343.45	2289.18	2187.93	2095.27	2115.43	2109.45

Source: S&P Global Market Intelligence. Standard template. Financial Sources.